Pharma Tech Outlook Conferences

10th Annual Pharma Pricing, Reimbursement & Market Access USA 2026 arrives at a critical turning point for the industry. With the global drug safety software market projected to exceed $350M by 2030, the shift toward digital transformation and AI-driven reporting is no longer optional—it is a regulatory requirement. This year, we unite a high-level ecosystem of Pharmaceutical, Biotech, and Regulatory stakeholders in Boston to dismantle silos and solve the most pressing challenges in the drug safety value chain.

The growing interest in alternative routes of drug and vaccine administration has experts predicting that the market for microneedle drug/vaccine delivery systems could exceed $30 billion by 2030. The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. That is why you cannot afford to miss Pharma Ed’s Microneedle & Transdermal Delivery Forum 2026. This two-day conference brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

ALS expansion to BMS and insistro's genetically driven collaboration and Clene Nanomedicine's regulatory-stage program—underscore the ALS community’s continued commitment to advancing impactful therapies, even in the face of clinical setbacks. With over 475 therapies in development, and 157 active or enrolling trials, and more than 350 companies actively working in ALS, and a global ALS market projected to grow from USD 667.3M in 2023 to USD 987.6M by 2030, confidence is returning. Learnings, fuelled by stronger mechanistic hypotheses, and more resilient translational strategies, spanning TDP 43 loss and gain of function biology, cryptic exon regulation, neuroinflammatory pathways, and human relevant iPSC and 3D models, the ALS community is leveraging these lessons to build smarter, more predictive programs.

The leading conference for experts on E&L, toxicology and medical devices.  The entire supply chain attends this event to learn about regulatory updates, submittal protocols, test plans and best-in-class case studies. To take 10% off your ticket, use code PTO26

The 7th TCR-Based Therapies Summit returns as the definitive forum dedicated to advancing the future of TCR-based cell and biologic therapies. Across three focused days, learn directly from industry pioneers at Immatics, Immunocore, Regeneron, BioNTech, Enara Bio, Zelluna Immunotherapy and more, as they share real-world lessons in advancing TCR therapies from discovery through to clinical development, manufacturing, and commercialization. Don’t miss out on unrivalled networking opportunities with industry-leading TCR developers, brand-new data presentations led by top biopharma professionals and insight into the only meeting dedicated to TCR-based therapy advancement.

Brings together senior pharma, biotech, and medical device marketers to explore omnichannel strategy, AI-driven engagement, and brand storytelling.

The Medical Affairs Nexus 2026 is an invitation-only, executive-level gathering that brings together senior Medical Affairs leaders from pharmaceutical and biotechnology organizations, alongside carefully selected solution providers driving innovation in medical strategy, scientific communication, and patient engagement. This event moves beyond the traditional conference model, delivering a multi-dimensional experience focused on knowledge exchange, peer-to-peer dialogue, and actionable insights. The agenda is thoughtfully curated to tackle the most critical challenges facing Medical Affairs today while highlighting emerging trends and innovative practices already delivering measurable impact.

The 3rd Measuring Patient Engagement Summit is the only forum entirely focused on turning patient engagement strategies into measurable, credible impact. Over three days, 70+ senior leaders from pharma, biotech, and patient advocacy will convene to explore frameworks, tools, and practical approaches that show how patient input drives outcomes across development, access, and commercialization.

The Pharma Partnering Summit (World Congress), scheduled for April 29–30, 2026 in San Diego, California, is a premier international event dedicated to fostering collaboration and deal-making across the pharmaceutical and biotech industries. Its central mission is to connect senior executives, business development leaders, and innovators to accelerate partnerships that drive medical breakthroughs and commercial success.

DUPHAT plays an important role in the pharmaceutical industry of the MEA region. Initially conceptualized as a conference and exhibition to support the local market, today it has become the leading regional educational and networking platform for leaders of the pharma sector. DUPHAT is a brand highly recognized by the pharma key players. DUPHAT is the unmissable pharmaceutical event in Middle East & Africa